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Cathepsin K Deficiency Reduces Elastase Perfusion–Induced
Abdominal Aortic Aneurysms in Mice
Jiusong Sun, Galina K. Sukhova, Jie Zhang, Han Chen, Sara Sjo¨berg, Peter Libby, Mingcan Xia,
Na Xiong, Bruce D. Gelb, Guo-Ping Shi
Objective—Cathepsin K (CatK) is one of the most potent mammalian elastases. We have previously shown increased
expression of CatK in human abdominal aortic aneurysm (AAA) lesions. Whether this protease participates directly in
AAA formation, however, remains unknown.
Methods and Results—Mouse experimental AAA was induced with aortic perfusion of a porcine pancreatic elastase. Using
this experimental model, we demonstrated that absence of CatK prevented AAA formation in mice 14 days
postperfusion. CatK deficiency significantly reduced lesion CD4 T-cell content, total lesion and medial cell
proliferation and apoptosis, medial smooth muscle cell (SMC) loss, elastinolytic CatL and CatS expression, and elastin
fragmentation, but it did not affect AAA lesion Mac-3 macrophage accumulation or CD31 microvessel numbers. In
vitro studies revealed that CatK contributed importantly to CD4 T-cell proliferation, SMC apoptosis, and other
cysteinyl cathepsin and matrix metalloproteinase expression and activities in SMCs and endothelial cells but played
negligible roles in microvessel growth and monocyte migration. AAA lesions from CatK-deficient mice showed reduced
elastinolytic cathepsin activities compared with those from wild-type control mice.
Conclusion—This study demonstrates that CatK plays an essential role in AAA formation by promoting T-cell
proliferation, vascular SMC apoptosis, and elastin degradation and by affecting vascular cell protease expression and
activities. (Arterioscler Thromb Vasc Biol. 2012;32:15-23.)
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The pathogenesis of human abdominal aortic aneurysm(AAA) involves extensive vascular wall matrix protein
remodeling, which requires the participation of proteases.1–3
Cysteine protease cathepsins K, L, and S are among the most
potent mammalian elastases.4 We showed previously that
human atherosclerosis and AAA lesions contained high levels
of these proteases.5 In contrast, their endogenous inhibitor
cystatin C was deficient in these lesions.6 Absence of these
proteases protected mice from diet-induced atherosclerosis,
whereas cystatin C-deficient mice had enlarged aortic diam-
eters,7–10 suggesting essential roles of cysteine proteases in
aortic wall remodeling. Since we first showed increased
expression of cathepsins S, L, and K in human AAA lesions,6
other studies have found similar expression patterns. Aortic
tissue extract cathepsin activities were significantly higher in
AAA patients than in those with aortic occlusion diseases, but
cystatin C levels were regulated inversely.11 Aortic tissues
from patients with growing AAA and ruptured AAA con-
tained significantly higher cathepsin mRNA and protein
levels than did control aortas,12 suggesting the involvement of
cathepsins in AAA pathogenesis, but a direct role of this class
of proteases has never been proven. In this study, we used
cathepsin K (CatK)–deficient mice and aorta elastase perfu-
sion–induced experimental AAA to test whether this elastase
contributes directly to AAA formation.
Materials and Methods
Mouse AAA Model and Lesion Characterization
Male 10-week-old CatK-deficient mice (Ctsk/, C57BL/6/129S
background)13 and male wild-type (Ctsk/) littermate controls
underwent aortic perfusion with 0.411 U/mL type I porcine pancre-
atic elastase (E1250, Sigma, St. Louis, MO) to produce experimental
AAA, as previously described.14 We used 9 or 10 mice per
experimental group and harvested the aortic tissues at 7 or 14 days
postperfusion. Mouse aortic diameters were measured using a
surgical microscope (Zeiss Stemi SV11) equipped with a micrometer
eyepiece (14 mm/0.1, SG02.T0218c, Motic Instruments, Inc, Van-
couver, British Columbia, Canada), which allowed us to read aortic
diameters at any time during the surgical procedure or during tissue
harvesting.14,15 The micrometer eyepiece was calibrated under each
magnification. Preperfusion, immediate postperfusion (5 minutes
after perfusion restoration), 7-day postperfusion, and 14-day post-
perfusion aortic diameters were measured to a resolution of 0.1 mm
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while mice were under anesthesia and physiological blood pressure.
Two independent investigators measured aortic diameters, with no
significant interobserver or intraobserver variability. Aortic diameter
expansion 100% of that before perfusion defined AAA.14 Each
mouse aorta was isolated for frozen section preparation (a total of 20
sections per aorta were prepared for immunohistology analysis) and
tissue protein extraction in a pH 5.5 buffer containing 1% Triton
X-100, 40 mmol/L sodium acetate, and 1 mmol/L EDTA.5 Frozen
sections were used for immunostaining for macrophages (Mac-3),
smooth muscle cells (SMCs) (-actin), T cells (CD4), endothelial
cells (ECs) (CD31), elastin (Verhoeff–van Gieson), apoptotic cells
(terminal deoxynucleotidyl transferase dUTP nick-end labeling) and
proliferating cells (Ki67), as described previously.7,15,16 Medial elastin
fragmentation and SMC contents were graded as described previously,
except that SMC content was presented as grades for medial SMC
loss.15 T cells, apoptotic cells, proliferating cells, and microvessels in the
adventitia were counted and compared blindly by 2 independent
observers to ensure reproducibility. Adventitial macrophage-positive
areas were measured with the use of computer-assisted image analysis
software (Image-Pro Plus; Media Cybernetics, Bethesda, MD).
Cysteine Protease Active Site Labeling and Gelatin
Gel Zymogram
SMCs and ECs were lysed into a pH 5.5 buffer. Five micrograms of
protein from each sample were incubated with 12 mmol/L dithio-
threitol and 1 L of biotin-conjugated JPM in 30 L of a pH 5.5
buffer for 1 hour at 37°C. Protein samples were then separated on a
12% SDS-PAGE gel, followed by immunoblot detection with
horseradish peroxidase-conjugated avidin (1:10 000, Sigma).3 Ma-
trix metalloproteinase (MMP) activity was detected with a gelatin gel
zymogram, essentially the same as reported previously.17 Equal
protein loading (20 g protein/lane) was confirmed with immuno-
blot analysis with goat anti-mouse -actin polyclonal antibodies
(1:2000, Santa Cruz Biotechnologies, Santa Cruz, CA).
Real-Time Polymerase Chain Reaction
Real-time polymerase chain reaction determined protease mRNA
levels in SMCs and ECs. Mouse aortic SMCs and ECs were prepared
from Ctsk/ mice and Ctsk/ mice, as reported previously.7,18
Aortic SMC purity was examined with the expression of -smooth
muscle actin and calponin.7 Total cellular RNA was extracted from
SMCs and ECs using TRIzol reagent (Invitrogen, Carlsbad, CA) and
treated with RNase-free DNase (Ambion, Austin, TX) to remove
genomic DNA contaminants. Equal amounts of RNA were reverse
transcribed, and quantitative polymerase chain reaction was assessed
in a single-color reverse transcription–polymerase chain reaction
detection system (Stratagene, La Jolla, CA). The level of each
protease transcript was normalized to that of the -actin transcript.
SMC Apoptosis
SMC apoptosis was performed using primary cultured Ctsk/ and
Ctsk/ mouse aortic SMCs on an 8-well chamber slide. Confluent
SMCs were stimulated to apoptosis overnight with 60 mol/L
pyrrolidine dithiocarbamate.19 Apoptotic cells were detected with In
Situ Cell Death Detection Kit according to the manufacturer’s
instructions (Roche Diagnostics Co., Indianapolis, IN).
Aortic Ring Assay
An aortic ring assay was used to test the role of CatK in angiogen-
esis. In brief, a 96-well plate was coated with 50 L of Matrigel (BD
Biosciences, San Diego, CA). Mouse aortic rings of 1 mm in length
from Ctsk/ and Ctsk/ mice were laid on top of the Matrigel and
covered with 100 L of Matrigel. After solidification, 150 L of
RPMI (10% FBS) was added to each well. After 7 to 10 days of
culture, the aortas were photographed, and the endothelial outgrowth
was analyzed using Image-Pro Plus software and presented as square
millimeters. Basic fibroblast growth factor (10 ng/mL, PeproTech,
Inc., Rocky Hill, NJ) was used as a positive control.
In Situ Elastin Zymography
AAA lesion elastinolytic activity was determined in 8-m frozen
sections using elastin conjugated with quenched fluorescein (DQ
elastin; Invitrogen) as a substrate, which requires cleavage by
elastinolytic enzymes to become fluorescent. In brief, DQ elastin (1
mg/mL in H2O) was mixed 1:10 with 1% low-melting agarose
(Sigma). This mixture (20 L) was added on top of each section,
coverslipped, and gelled at 4°C. Following incubation at 37°C (48
hours), fluorescence was examined under fluorescent microscopy.
Cysteine protease activity was determined using an EDTA-
containing pH 5.5 buffer5 with or without a generic cathepsin
inhibitor E64d (20 mol/L). Zymographic images were acquired
using identical shutter conditions. The percentage of fluorescence
intensity of each cross section, excluding the media area because of
medial elastin filament autofluorescence, was measured using
computer-assisted image quantification (Image-Pro Plus software).
Medial cathepsin elastase activity was calculated by subtracting the
Figure 1. Reduced abdominal aortic aneurysm (AAA) formation in Ctsk/ mice. Aortic diameters in both Ctsk/ mice and Ctsk/ mice
were measured preperfusion, immediately postperfusion, and at 7 and 14 days postperfusion. The number of mice per group is indicated in
each bar. Data are meanSE. P0.05 is considered statistically significant; *nonpaired Mann-Whitney U test, **paired Wilcoxon signed-rank test.
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percentages of fluorescence intensity in media regions of E64d-
treated sections from those of untreated sections.
Cell Proliferation Assay
CD4 T cells were purified from splenocytes by depleting major
histocompatibility complex class II–positive cells and CD8 T cells
using anti-mouse I-Ab and CD8 monoclonal antibodies (BD Biosci-
ences), followed by complement depletion, as described previ-
ously.20 Monocytes were isolated from peripheral blood by Percoll
(Sigma) gradient centrifugation. T-cell and monocyte proliferation
were assessed with the Cell Titer 96AQ Assay kit, according to the
manufacturer’s instructions (Promega, Madison, WI). Equal numbers
of T cells and monocytes from Ctsk/ mice and Ctsk/ mice were
plated on 96-well plates at serial dilutions in 100 L of 10% FBS RPMI
1640 per well and cultured for 2 days at 37°C. Then, 20 L of a mixture
of tetrazolium compound and phenazine methosulfate was added, and
the absorbance was determined at 492 nm. Monocyte proliferation was
determined under spontaneous conditions, whereas CD4 T-cell prolif-
eration was measured in the presence of anti-CD3 monoclonal antibod-
ies (1 g/mL, Pharmingen, San Diego, CA). Serial dilutions of known
numbers of T cells and monocytes were used to generate standard
curves.
Transmigration Assay
T-cell and monocyte transmigration assay was performed on a type
I collagen (100 ng/25 L per well in a pH7.0 HEPES buffer)–
precoated 96-well Chemotaxis plate, according to the manufacturer’s
instructions (Neuro Probe, Inc, Gaithersburg, MD). Stromal cell-
derived factor-1 (0, 10, 100, and 1000 ng/mL, PeproTech) in a plain
RPMI containing 1% bovine serum albumin (Sigma) was used as
chemokine. Although stromal cell-derived factor-1 is an important
chemokine for stem cells or progenitor cells, it has been widely used
in inflammatory cell in vitro migration assays.21–23 Briefly, T cells
and monocytes (25 000 cells in 25 L of 1% bovine serum albumin
RPMI) were seeded on the top of the filter, and 30 L of stromal
cell-derived factor-1 was added to the bottom chamber. After
incubation (3 hours for monocytes; 1.5 hours for T cells), the
remaining filter top cells were removed, and the bottom cells were
collected (1500 rpm, 5 minutes), fixed with 1% paraformaldehyde,
and counted by fluorescence-activated cell sorting analysis.
Blood Cell and Splenocyte Fluorescence-Activated
Cell Sorting Analysis
Blood cells and splenocytes from Ctsk/ mice, Ctsk/ mice, and
those treated with angiotensin II (Ang II) were analyzed for contents
of Ly6G, CD11b, CD4, and CD8 cells. To treat Ctsk/ and
Ctsk/ mice with Ang II, mice received Alzet osmotic minipumps
(model 2004, Alzet, Durect Corp, Cupertino, CA) filled with Ang II
(Sigma, 1000 ng/kg/min). Blood samples were collected after 28
days. Total blood cells were isolated by cardiac puncture, and
splenocytes were prepared as described previously.20 Blood cells and
splenocytes were stained with rat anti-mouse Ly6G-FITC (RB6–
Figure 2. Cathepsin K (CatK) activities on T-cell proliferation. Absence of CatK did not affect abdominal aortic aneurysm (AAA) lesion
Mac-3 macrophage-positive area (A) but reduced CD4 T-cell numbers (B) in the adventitia at 14 days postperfusion. In vitro cell pro-
liferation assay showed that CatK deficiency impaired CD4 T-cell proliferation (C). In AAA lesion adventitia, numbers of Ki67-positive
cells (D) and percentage of CD4 T-cells among Ki67-positive cells (E; arrows indicate Ki67CD4 T cells) were also reduced in
Ctsk/ mice at 14 days postperfusion. The number of mice per group is indicated in each bar. All data are meanSE. P0.05 is con-
sidered statistically significant; Mann-Whitney U test. Representative images are shown to the right in B, D, and E.
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8C5, eBioscience), rat anti-mouse CD11b-PE (M1/70, eBioscience,
San Diego, CA), rat anti-mouse CD4-PE (GK1.5, Biolegend, San
Diego, CA), and rat anti-mouse CD8-Alexa 610 (5H10, Invitrogen).
Ly6G, CD11b, CD4, and CD8 cell percentages were deter-
mined by fluorescence-activated cell sorting analysis (Cytomics
FC500, Beckman Coulter, Brea, CA).
Statistical Analysis
Because of relatively small sample sizes and data distribution
abnormality, we selected the nonparametric Mann-Whitney U test
for nonpaired data sets and the Wilcoxon signed-rank test for paired
data sets to examine statistical significance throughout this study.
P0.05 was considered statistically significant.
Results
Reduced AAA in CatK-Deficient Mice
Both Ctsk/ mice and Ctsk/ mice underwent aortic elastase
perfusion to induce AAA. In mice used for the 7-day time point,
there were no significant differences in aortic diameters between
Ctsk/ mice and Ctsk/ mice before and immediately after
elastase perfusion. At 7 days postperfusion, Ctsk/ mice and
Ctsk/ mice also showed no significant differences in aortic
diameters, and none of these mice developed AAA, as defined by a
100% increase in aortic diameter (Figure 1A).14 In Ctsk/ mice
used for the 14-day time point, both preperfusion (0.55
0.01 versus 0.480.01 mm, P0.001) and immediate postperfu-
sion (0.870.03 versus 0.790.02 mm, P0.02) aortic diameters
were larger than those from Ctsk/ mice, although we cannot
explain this observation. At 14 days postperfusion, however, aortic
diameters from Ctsk/ mice were not significantly different from
those immediately postperfusion (P0.562) but were significantly
smaller that those from Ctsk/ mice (P0.001) (Figure 1B). At
this time point, all Ctsk/ mice (10 of 10) developed AAA, but
none of the Ctsk/ mice did.
Inflammatory Cells in AAA Lesions
Inflammatory cell infiltration is an important event following
AAA initiation in humans and animals.24 Although we
detected no significant differences in lesion macrophage
Figure 3. Cathepsin K (CatK) activities on lesion cell apoptosis. Abdominal aortic aneurysm (AAA) lesion adventitia (A) and medial (B)
terminal deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL)–positive cell numbers were significantly lower in Ctsk/ mice
than in Ctsk/ mice at 14 days postperfusion. At the same time point, lesion medial smooth muscle cell (SMC) loss was reduced in
Ctsk/ mice (C). The number of mice per group is indicated in each bar. Aortic SMCs from Ctsk/ mice were resistant to pyrrolidine
dithiocarbamate (PDTC)-induced apoptosis (D). All data are meanSE. P0.05 is considered statistically significant; Mann-Whitney U
test. Representative images are shown to the right in A, B, and C.
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contents between Ctsk/ and Ctsk/ mice at either time
point (Figure 2A), Ctsk/ mouse AAA lesions contained
significantly higher numbers of CD4 T cells than did
Ctsk/ AAA lesions at 14 days postperfusion (Figure 2B).
The reduced numbers of CD4 T cells in Ctsk/ mouse
lesions suggest that CatK activity contributed to T-cell
migration or proliferation. To test these possibilities, we
performed Boyden chamber cell transmigration assay using
stromal cell-derived factor-1 as a chemoattractant. When
either monocytes or CD4 T cells were used, we did not
detect significant differences in their transmigration through
collagen-coated Transwells (Neuro Probe Inc.) with or with-
out CatK (data not shown). In contrast, CD4 T cells (Figure
2C), but not monocytes (data not shown), proliferated differ-
ently between the 2 genotypes. CD4 T cells from Ctsk/
mice proliferated much faster than those from Ctsk/ mice.
These data may explain the unchanged macrophage content but
reduced CD4 T-cell content in Ctsk/ mouse AAA lesions
(Figure 2A and 2B). In AAA lesions, Ki67 proliferating cells
were significantly reduced in Ctsk/ mice, compared with
those in Ctsk/ mice at 14 days postperfusion (Figure 2D).
Anti-CD4 and anti-Ki67 monoclonal antibody coimmunostain-
ing examined proliferating CD4 T cells in AAA lesions.
Among all Ki67 proliferating cells, the percentages of CD4 T
cells were significantly lower in Ctsk/ mice than in Ctsk/
mice (Figure 2E), suggesting a role for CatL in T-cell prolifer-
ation in vivo.
CatK Function in Vascular Cell Apoptosis
SMC apoptosis determines tunica media thinning and char-
acterizes both human and animal AAA lesions,25–27 whereas
infiltrating leukocytes release apoptotic stimuli to promote
vascular cell apoptosis.26,28 The absence of CatK reduced
AAA lesion apoptotic cells significantly. Terminal deoxynu-
cleotidyl transferase dUTP nick-end labeling–positive cells
were reduced in whole AAA lesions (Figure 3A) and in the
media (Figure 3B, mainly SMCs) from Ctsk/ mice, com-
pared with those in Ctsk/ mice at 14 days postperfusion. In
correlation with this observation, medial SMC loss in AAA
lesions from Ctsk/ mice also was significantly impaired at
this time point (Figure 3C), although both lesion cell apopto-
sis and medial SMC loss were not significantly different
between the phenotypes at the 7-day time point (Figure 3A
and 3C). To examine the contribution of CatK to SMC
apoptosis, we induced SMC apoptosis with pyrrolidine di-
thiocarbamate. When SMCs from Ctsk/ mice underwent
apoptosis in the presence of pyrrolidine dithiocarbamate,
those from Ctsk/ mice were protected (Figure 3D). Al-
though the mechanisms behind these observations merit
further investigation, these results suggest an important role
of CatK in SMC apoptosis.
CatK Deficiency Protected Medial
Elastin Fragmentation
Elastin fragmentation is an important hallmark of human
AAA29 and is mediated by elastases in the media. As one of
the most potent elastases, CatK may participate directly in
medial elastin degradation. Verhoeff–van Gieson staining
demonstrated significantly reduced elastin fragmentation in
AAA lesions from Ctsk/ mice compared with those from
Ctsk/ mice at 7 days postperfusion. Elastin degradation
was enhanced at the later time point and remained lower in
Ctsk/ mice than in Ctsk/ mice at 14 days postperfusion,
although it did not reach statistical significance (2.390.26
versus 2.790.22, P0.171) (Figure 4A). Insignificance in
elastin degradation between the groups at this time point was due
to an outlier aorta in each group of mice. Significant differences
in AAA expansion (Figure 1B) but insignificant medial elastin
fragmentation (Figure 4A) between Ctsk/ mice and Ctsk/
mice at 14 days postperfusion suggest that medial elastin
degradation is merely part of the mechanism of murine AAA
formation. Other mechanisms, such as inflammatory cell infil-
tration, medial cell apoptosis, and SMC loss, also contribute to
the pathogenesis.
CatK deficiency can alter expression or activities of other
elastases—and consequently impair elastin fragmenta-
tion—in AAA lesions from Ctsk/ mice. Real-time poly-
merase chain reaction showed increased CatL transcript and
decreased MMP-2 transcripts in SMCs from Ctsk/ mice, as
compared with Ctsk/ mice (Figure 4B). Although SMCs
routinely express MMP-2, they also express MMP-9 at much
lower levels,30,31 and CatK deficiency did not affect MMP-9
mRNA levels significantly (Figure 4B). Cysteinyl cathepsin
Figure 4. Cathepsin K (CatK) activities on medial elastin frag-
mentation and aortic smooth muscle cell (SMC) protease
expression. At both time points (7 and 14 days postperfusion),
medial elastin fragmentation in abdominal aortic aneurysm (AAA)
lesions from Ctsk/ mice were lower than in Ctsk/ mice (A).
The number of mice per group is indicated in each bar. Data are
meanSE. Cathepsin and matrix metalloproteinase (MMP) tran-
scripts in aortic SMCs were examined by real-time polymerase
chain reaction (B). Data are meanSE of 4 independent experi-
ments. P0.05 is considered statistically significant; Mann-
Whitney U test. Cysteinyl cathepsin activities in SMCs were
examined by active site JPM labeling (C). Actin immunoblot was
used as protein loading control. MMP activities were assessed
by gelatin gel zymogram assay (D).
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active site labeling with JPM in SMCs from Ctsk/ mice,
however, revealed reduced activity of CatL (Figure 4C),
another potent elastase that is abundant in human AAA.32
In a separate study, we proved that the absence of CatL
prevented mice from elastase perfusion–induced AAA,
with concomitant reduction of media elastin fragmentation
(G.-P. Shi, unpublished data). Furthermore, MMP-2 and
MMP-9 activities were reduced in SMCs from Ctsk/
mice, as demonstrated in a gelatin gel zymogram assay
(Figure 4D). MMP-2 and MMP-9 may play essential roles
in murine experimental AAA formation.14,33 Reduced
MMP activities in Ctsk/ mouse SMCs may indirectly
contribute to the protection of elastase perfusion–induced
AAA.
Impaired elastinolytic cathepsin activities in AAA le-
sions from Ctsk/ mice was further illustrated in an in
situ elastase zymogram assay to detect lesion elastinolytic
cathepsin activity3,15,16 and immunostaining to detect 2
common elastinolytic CatL and CatS in the media. When
8-m unfixed cross sections from AAA lesions were used
to digest fluorogenic DQ-elastin,5 AAA lesions from
Ctsk/ mice contained elastinolytic cathepsin activities in
the adventitia regions that could be inhibited by 20 mol/L
of a nonselective cathepsin inhibitor E64d (Figure 5A, top
panels). Reduced elastinolytic cathepsins in adventitia
from Ctsk/ AAA lesions may result from impaired
lesion inflammatory cell infiltration and proliferation (Fig-
ure 2B to 2E). We focused on elastinolytic cathepsin
activities in the adventitia, separated from media by dotted
lines in Figure 5A, mainly because of the interference of
internal elastica autofluorescence. In contrast, AAA sec-
tions from Ctsk/ mice contained much lower adventitia
elastinolytic cathepsin activities that were further inhibited
by E64d (Figure 5A, bottom panels). To examine elasti-
nolytic cathepsin activities in the media, we subtracted the
percentages of media fluorescence of E64d-treated sec-
tions from those of untreated sections. Using this method,
we found that the percentages of medial cathepsin activity
from Ctsk/ mice were significantly higher than those
from Ctsk/ mice (P0.0001, Figure 5B). To confirm
further altered medial cathepsin expression and activity
differences between the groups, we performed immuno-
staining for CatL and CatS, 2 potent mammalian elastases.
Medial expressions of CatL and CatS were reduced in
AAA lesions from Ctsk/ mice compared with those from
Ctsk/ mice (Figure 5C), which is consistent with re-
duced medial elastase activity (Figure 5B) and elastinoly-
sis in these AAA lesions (Figure 4A).
Figure 5. Elastinolytic cysteinyl cathepsins in abdominal aortic aneurysm (AAA) lesions at 14 days postperfusion. A, In situ cysteinyl elastino-
lytic activity fluorescent zymogram assay. High cathepsin activities in the adventitia of AAA lesions in Ctsk/ mice (top left) could be largely
inhibited by E64d (top right). Elastinolytic cathepsin activities were reduced in AAA lesion adventitia from Ctsk/ mice (bottom left), and
E64d further reduced cathepsin activities (bottom right). The percentages of adventitia fluorescence yielded from fluorogenic elastin degrada-
tion represented cysteinyl cathepsin activities. The white dotted lines separate medial elastin autofluorescence from the adventitia. B, Medial
fluorescence subtractions between E64d-treated and untreated sections determined medial elastinolytic cathepsin activities, which were sig-
nificantly reduced in the absence of cathepsin K (CatK). The number of mice per group is indicated in each bar. C, Immunostaining detected
medial CatL and CatS expression in AAA lesions from Ctsk/ and Ctsk/ mice. Med. indicates media; Adv., adventitia.
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CatK Expression and Activities in ECs
and Angiogenesis
Increased angiogenesis associates with AAA growth.34 Neo-
vascularization provides paths for inflammatory cell accumu-
lation in human AAA lesions.35 Reduced AAA growth in
Ctsk/ mice might be caused by impaired angiogenesis. To
test this hypothesis, we immunostained aortic sections with
anti-mouse CD31 antibodies and found lower CD31 mi-
crovessel numbers in lesions from Ctsk/ mice than in those
from Ctsk/ mice at 14 days postperfusion, but the differ-
ence did not reach statistical significance (Figure 6A). These
observations suggest that CatK activities in angiogenesis
contribute partially to pathogenesis in this experimental
AAA. In vitro aortic ring assays yielded similar results. When
aortic rings from Ctsk/ mice and Ctsk/ mice were used,
we did not see significant differences in microvessel growth
area in the absence (0.440.39 versus 0.350.32 mm2,
P0.05) or presence (5.341.86 versus 5.342.59 mm2,
P0.05) of proangiogenic factor basic fibroblast growth
factor. A mild effect of CatK in angiogenesis is consistent
with nearly “unchanged” EC protease activities. Although
real-time polymerase chain reaction revealed decreased CatB
transcript and increased MMP-2 transcript in ECs from
Ctsk/ mice, cathepsin active site labeling with JPM dem-
onstrated that CatK deficiency impaired EC CatS activity,
with compensatory increase of CatL activity (Figure 6C).
Gelatin gel zymogram assay showed that CatK deficiency did
not affect EC MMP-9 or MMP-2 activities (Figure 6D).
Discussion
Cathepsins have been implicated in human AAA formation
despite a lack of direct proof. This study provides the first
evidence that cathepsins participate directly in AAA patho-
genesis. Although many more mechanisms remain unknown,
we demonstrated that CatK contributed to AAA formation by
regulating lesion T-cell proliferation, SMC apoptosis, and
medial vascular cell protease expression or activities. CatK
deficiency protected mice from elastase perfusion–induced
experimental AAA.
An earlier study from Bai et al, using apolipoprotein E and
CatK double-deficient (Apoe/Ctsk/) mice, showed that
the absence of CatK did not affect AAA progression in Ang
II–induced experimental AAA.36 These prior observations
did not support a role for CatK in mouse AAA pathogenesis.
Compensatory induction of other cathepsins in Apoe/
Ctsk/ mice, although not tested in the study by Bai et al,
may explain their findings; different experimental models
also may contribute to the insignificant effect of CatK in Ang
II–induced AAA between Apoe/ mice and
Apoe/Ctsk/ mice. Bai et al discovered unexpectedly that
Ang II infusion enhanced peripheral active CD4CD25 T
cells and Ly6G leukocytes in Apoe/Ctsk/ mice. Such
Ang II–induced peripheral inflammatory cell population
changes may contribute in part to increased AAA lesion
CD45 leukocytes and Mac-3 macrophages, thereby in-
creasing expression of CatS and CatC in AAA lesions from
Apoe/Ctsk/ mice.36 The absence of a mutant Apoe allele
and Ang II treatment in this study may eliminate these
confounding factors and therefore reflect the true function of
CatK in AAA pathogenesis.
To assess whether Ang II treatment alone may alter the
peripheral inflammatory cell population, we treated both
Ctsk/ and Ctsk/ mice with Ang II for 28 days and then
analyzed peripheral blood and spleen leukocyte populations.
Blood total Ly6G neutrophils and Ly6GCD11b activated
neutrophils37 were not different between untreated Ctsk/
mice and Ctsk/ mice. Although Ang II infusion did not
yield appreciable AAA in either Ctsk/ mice or Ctsk/
mice, it significantly increased blood total neutrophils and
activated neutrophils in Ctsk/ mice, while showing no
effects on Ctsk/ mice. Blood CD11b cells (eg, mono-
cytes, macrophages, and natural killer T cells) were signifi-
cantly fewer in Ctsk/ mice than in Ctsk/ mice, and Ang
II treatment did not affect these populations in blood (Supplemental
Figure IA, available online at http://atvb.ahajournals.org). Blood
CD4 and CD8 T-cell populations were also affected by
Ang II. Before Ang II infusion, Ctsk/ mouse blood
contained significantly fewer CD4 cells and CD4CD25
activated CD4 cells, but more CD8 cells and CD4CD8
cells. After 28 days of Ang II infusion, all these differences
were impaired at different levels (Supplemental Figure IB
and IC). In spleen, Ly6G cells, CD11b cells, and
Ly6GCD11b cells were similar between Ctsk/ mice
and Ctsk/ mice. Ang II infusion increased Ly6G and
Ly6GCD11b cells and reduced CD11b cells similarly in
both Ctsk/ mice and Ctsk/ mice (Supplemental Figure
IIA). Furthermore, more CD4 cells and fewer CD8 cells in
Ctsk/ spleen were reversed after Ang II treatment (Supple-
mental Figure IIB), which also reduced spleen activated
CD4CD25 cells in both Ctsk/ mice and Ctsk/ mice
(Supplemental Figure IIC). Altered peripheral inflammatory
Figure 6. Cathepsin K (CatK) activities on angiogenesis and
endothelial cell (EC) protease expression. CD31 microvessel
numbers were not significantly different in abdominal aortic
aneurysm (AAA) lesions between the genotypes at both time
points (A). EC cathepsin and matrix metalloproteinase (MMP)
transcription levels were assessed by real-time polymerase
chain reaction (B). Cysteine protease active site labeling with
JPM (C) and gelatin gel zymogram (D) were used to assess EC
cathepsin and MMP activities, respectively.
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cell profiles in Apoe/ mice after Ang II infusion therefore
may have confounded AAA progression, thus obscuring the
contribution of CatK.36
Although we did not examine them in this study, cysteinyl
cathepsins induce cell apoptosis by cleaving the antiapoptotic
protein Bcl-2 member Bid and creating proapoptotic signal
for mitochondrial cytochrome C release.38 For example,
CatB-deficient mice showed reduced cerebral cell losses,
whereas a mutation on cystatin resulted in increased apopto-
sis of cerebellar granule cells.39 Osteoclasts from Ctsk/
mice showed increased growth due to reduced apoptosis and
senescence.40 Reduced apoptosis in AAA lesions from
Ctsk/ mice may use the same mechanism. Cysteinyl
cathepsins also regulate lymphocyte proliferation with com-
plicated mechanisms. Prior studies have suggested that cathe-
psins promote T-cell proliferation by degrading matrix pro-
teins in the lymphoid organs,41 activating transcription factor
nuclear factor-B,42 and regulating 2 integrin receptor
lymphocyte function-associated antigen-1 activity.43,44 Con-
sistent with these prior studies, our study showed impaired
proliferation of CD4 T cells isolated from Ctsk/ spleno-
cytes compared with those from Ctsk/ splenocytes, which
helped to explain reduced CD4 T cells in aortic tissues from
Ctsk/ mice (Figure 2B and 2C). Total CD4 cells in
spleen, however, were fewer in Ctsk/ mice than in Ctsk/
mice. Ang II infusion reversed splenic CD4 cell profiles.
Similar mechanisms may occur in the aortic wall during the
progression of AAA. All such speculations merit further
investigation.
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Supplemental Figure I. FACS characterization of blood leukocytes from Ctsk+/+ mice 
and Ctsk–/– mice treated with and without Ang-II. A. Ly6G+, CD11b+, and Ly6G+CD11b+ 
cell percentages. B. CD3+CD4+, CD3+CD8+, CD3+CD4+CD8+ cell percentages. C. 
CD3+CD4+CD25+ cell percentage. SS log: side scatter log value. Representative FACS 
for each genotype and treatment is shown to the left. Data are mean ± SE from 3~5 mice 
per group. P<0.05 is considered statistically significant; Mann-Whitney U test. 
Supplemental Figure II. FACS characterization of spleen leukocytes from Ctsk+/+ mice 
and Ctsk–/– mice treated with and without Ang-II. A. Ly6G+, CD11b+, and Ly6G+CD11b+ 
cell percentages. B. CD3+CD4+, CD3+CD8+, CD3+CD4+CD8+ cell percentages. C. 
CD3+CD4+CD25+ cell percentage. SS log: side scatter log value. Representative FACS 
for each genotype and treatment is shown to the left. Data are mean ± SE from 3~5 mice 
per group. P<0.05 is considered statistically significant; Mann-Whitney U test. 
